Facilitating Physical Activity Behavior and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy

NCT ID: NCT01053468

Last Updated: 2011-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-08-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Breast cancer and its treatments can take a toll on the physical and psychosocial well-being of cancer survivors. Few interventions can help breast cancer patients improve their physical strength, stamina, and overall well-being. Developing ways to facilitate PA behavior during chemotherapy for breast cancer are necessary. This trial explores ways that breast cancer patients receiving chemotherapy can learn about and engage in PA during chemotherapy. This trial will also give Southern Alberta breast cancer survivors an opportunity to participate in evidence-based programs designed to facilitate their health, breast cancer recovery, and disease-free survival.

The investigators primary hypothesis is that women receiving the PA intervention resource kit will report a more positive change in self-reported PA at the end of chemotherapy treatments when compared to the group receiving standard materials.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objective:

To compare the effects of an evidence-based intervention consisting of targeted breast-cancer specific PA print materials (i.e., Exercise for health), a step pedometer, a step-walking guidebook (i.e., Step into survivorship), and a physical activity and step journal (INT) to a comparison group receiving a generic, two-page public health PA resource (Standard Material: SM).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PA Behavior Intervention

Physical Activity Resource Kit

Group Type EXPERIMENTAL

Physical Activity Resource Kit

Intervention Type BEHAVIORAL

The Intervention group (INT) will receive a Physical Activity Resource Kit which includes a step pedometer, a breast cancer-specific Physical Activity Guidebook (Exercise for health), a step pedometer resource (Step into survivorship), and a physical activity and step journal to record their daily step totals and daily physical activities.

Participants will be instructed to wear their pedometer for the entire duration of the study (i.e., chemotherapy duration).

Standard Materials

Receive physical activity handout from the Canadian Public Health Agency

Group Type ACTIVE_COMPARATOR

Standard Materials

Intervention Type BEHAVIORAL

Participants in this usual care group will receive a generic physical activity leaflet from the Canadian Public Health Agency

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical Activity Resource Kit

The Intervention group (INT) will receive a Physical Activity Resource Kit which includes a step pedometer, a breast cancer-specific Physical Activity Guidebook (Exercise for health), a step pedometer resource (Step into survivorship), and a physical activity and step journal to record their daily step totals and daily physical activities.

Participants will be instructed to wear their pedometer for the entire duration of the study (i.e., chemotherapy duration).

Intervention Type BEHAVIORAL

Standard Materials

Participants in this usual care group will receive a generic physical activity leaflet from the Canadian Public Health Agency

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* are diagnosed with stage I -IIIA breast cancer
* are scheduled to receive neoadjuvant or adjuvant chemotherapy
* did not receive transabdominal rectus abdominus muscle (TRAM) reconstructive surgery
* are \>18 years of age
* receive approval from their treating oncologist to participate
* do not have uncontrolled hypertension, cardiac illness, or psychiatric conditions (i.e., indicated in patient medical charts).
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alberta

OTHER

Sponsor Role collaborator

University of Calgary

OTHER

Sponsor Role collaborator

Alberta Health services

OTHER

Sponsor Role collaborator

Athabasca University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Athabasca University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeff Vallance, PhD

Role: PRINCIPAL_INVESTIGATOR

Athabasca University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tom Baker Cancer Centre

Calgary, Alberta, Canada

Site Status RECRUITING

Grande Prairie Cancer Centre

Grande Prairie, Alberta, Canada

Site Status RECRUITING

Lethbridge Cancer Centre

Lethbridge, Alberta, Canada

Site Status RECRUITING

Medicine Hat Cancer Centre

Medicine Hat, Alberta, Canada

Site Status RECRUITING

Central Alberta Cancer Centre

Red Deer, Alberta, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jeff Vallance, PhD

Role: CONTACT

403-488-7179

Celeste Lavallee, BSc, RD

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PROACTIVE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.